A recent study suggest that cannabidiol can be used to treat epilepsy
Cannabidiol Cannabidiol is a new compound discovered by researchers that have been shown to reduce anxiety in patients suffering from social phobia. It was found that it inhibits THC-elicited paranoid symptoms. Another study also found that it inhibited the development of hippocampal-dependent memory impairment in rats. According to the journal Neuropsychopharmacology, it suppressed nitric oxide production in beta-amyloid-stimulated PC12 neurons. In addition to reducing seizure frequency and severity, Cannabidiol also reduces adverse events, such as seizures. In animal studies, it is associated with fewer adverse events and increased plasma levels. The benefits of this can be seen in humans, too, although the FDA has not evaluated it as yet. It is still necessary to do further research before recommending it for human use. A recent study published in the journal Neuropsychopharmacology reported that cannabidiol reduced the anxiety levels of patients suffering from social phobia
